Prof. Eugenio Garribba

Position: Full Professor of General and Inorganic Chemistry; Director of the PhD School of the University of Sassari
 

Scopus Researchgate

Prof. Eugenio Garribba is a Full Professor of General and Inorganic Chemistry at the Department of Medicine, Surgery and Pharmacy of the University of Sassari. After obtaining his degree in Chemistry (1994–95) and a PhD in Chemical Sciences (2002), he began his academic career as a researcher in 2004, was promoted to Associate Professor in 2016, and to Full Professor in 2022.

At the institutional level, Prof. Garribba served as the Rector’s Delegate for Student Orientation and Job Placement (2014–2017) and, since 2022, has been Director of the PhD School, a role in which he coordinates interdisciplinary advanced training programs. He has taught 48 university courses, supervised more than thirty undergraduate and master’s theses, and served as advisor to three PhD candidates in Chemical Sciences and Technologies.

His research interests concern the bioinorganic chemistry of transition metals, the design and mechanism of action of new metal-based drugs and their interaction with biomolecules, and the application of computational techniques to the determination of molecular, electronic, magnetic and spectroscopic properties of coordination compounds.

His scientific output includes 242 articles (h-index 50) published in international peer-reviewed journals, more than one hundred of which list him as corresponding author. He appears in the Top 2% Scientist List compiled by Stanford University and is included among the top 300 Italian Top Scientists in the field of Chemistry.

The international scope of his research is evidenced by collaborations with more than fifty universities and research centers across five continents. He has participated in PRIN, MURST, and FAR projects, as well as in two COST Actions, and has coordinated initiatives funded by the Fondazione di Sardegna and the Sardinia Regional Government. He is currently the National Coordinator of the PRIN 2022 project “TRILLI”, focused on the rational design of new low-cost metallodrugs through thermodynamic, spectroscopic, and biological approaches.